SureTrader Advertisement SureTrader
Home > Boards > US Listed > Biotechs >

Ariad Pharmaceuticals, Inc. (ARIA)

ARIA RSS Feed
Add ARIA Price Alert      Hide Sticky   Hide Intro
Moderator: 2damoon1, Jesspro, idig
Search This Board:
Last Post: 5/1/2016 12:19:04 AM - Followers: 338 - Board type: Free - Posts Today: 1



http://www.ariad.com/
http://finance.yahoo.com/q/ks?s=ARIA
http://phx.corporate-ir.net/phoenix.zhtml?c=118422&p=irol-news&nyo=0

The name ARIAD originates from the Greek myth of Ariadne, a daughter of Minos II, king of Crete. According to the myth, Ariadne fell in love with Theseus and gave him a spool of thread that enabled him to trace his path safely in and out of the labyrinth in which the Minotaur lived.

After slaying the Minotaur, Theseus used the spool of thread to successfully return home. From ARIAD's perspective, the labyrinth symbolizes the complex system of molecular pathways within the cell, and the spool of thread represents the signaling pathways that are leading our scientists to the discovery of breakthrough cancer therapies.

http://data.cnbc.com/quotes/ARIA/tab/8


 http://data.cnbc.com/quotes/ARIA/tab/8

 








 



 

ARIA charts here.

smileysmileysmileysmileysmileysmileysmileysmiley


http://investorshub.advfn.com/boards/read_msg.aspx?message_id=75384935



 










 

  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
ARIA
Current Price
Volume:
Bid Ask Day's Range
Wiki
SureTrader
ARIA News: Amended Annual Report (10-k/a) 04/29/2016 06:37:40 PM
ARIA News: ARIAD to Webcast Conference Call on First Quarter 2016 Financial Results 04/26/2016 07:35:00 AM
ARIA News: Current Report Filing (8-k) 04/25/2016 04:07:59 PM
ARIA News: Statement of Changes in Beneficial Ownership (4) 04/25/2016 04:05:48 PM
ARIA News: ARIAD Announces Results of Preclinical Studies on AP32788 at the Annual Meeting of the American Association for Cancer Research 04/19/2016 07:35:00 AM
PostSubject
#72584  Sticky Note Got it, Paris and Achilles. I saw alphahelix1 04/26/16 08:35:18 AM
#72660   Orphan Drug Status for brigatinib - Jesspro 05/01/16 12:19:04 AM
#72659   that is a long one '2da' galtjohn61 04/30/16 08:53:44 PM
#72658   Read question 1 in this letter, referencing the 2damoon1 04/30/16 06:30:37 PM
#72657   BO has been advocated since Denner's inception in Jesspro 04/30/16 05:47:34 PM
#72656   Pls explain.. alphahelix1 04/30/16 05:46:56 PM
#72655   The company needs competent, honest advisors with real biotech_researcher 04/30/16 05:22:53 PM
#72654   I disagree. One of the BoD's primary 2damoon1 04/30/16 04:47:29 PM
#72653   IMO and Paris and Denner have a pretty alphahelix1 04/30/16 03:29:54 PM
#72652   Thanks. Its wonderful having your input on this board. AK-PROARIAD 04/30/16 10:51:28 AM
#72651   I think chances for a buyout have been 2damoon1 04/30/16 10:49:17 AM
#72650   do you think there is a good possibility AK-PROARIAD 04/30/16 10:29:20 AM
#72649   Hasn't so far, even though Orphan Drugs tend 2damoon1 04/30/16 10:11:04 AM
#72648   Will the Orphan Status for Brigatinib help PPS AK-PROARIAD 04/30/16 09:16:57 AM
#72647   br - 2 vp's gone from the masthead. 2damoon1 04/29/16 10:58:40 PM
#72646   Did anyone notice that the company reissued its 2damoon1 04/29/16 10:48:37 PM
#72645   What about in a merger? investor maven 04/29/16 01:02:23 PM
#72644   Orphan Drug designation and approvals LUMA14 04/29/16 10:39:49 AM
#72643   NOLS I remember when Covanta bought DHC (Sam tobey123 04/28/16 05:03:40 PM
#72642   Drip, Drip, Drip...eom wilco244 04/28/16 03:51:46 PM
#72641   That is not true AK-PROARIAD 04/28/16 02:39:53 PM
#72640   NOL cannot be transferred if ownership changes. smallbio 04/28/16 02:13:42 PM
#72639   As I recall, NOLs are not easy to monetize ilpapa 04/28/16 12:36:24 PM
#72638   As I recall, the purported reason for the rumrunner528 04/28/16 11:57:10 AM
#72637   I would think that 1.5 billion of AK-PROARIAD 04/28/16 11:29:26 AM
#72636   You are correct, the NOLs are very valuable investor maven 04/28/16 11:22:40 AM
#72635   Some links for my last post: 2damoon1 04/28/16 10:13:14 AM
#72634   How much does Ariad's management/BoD of TC's science 2damoon1 04/28/16 10:09:05 AM
#72633   Ariafan, I'd recommend that you stop following alphahelix1 04/28/16 09:46:22 AM
#72632   Whew - I thought you were implying Ariad yankees7 04/28/16 09:12:17 AM
#72631   They are (about 35% of the total), but 2damoon1 04/28/16 08:54:37 AM
#72630   What about Ariads accumulated NOLs? They must AK-PROARIAD 04/28/16 08:47:39 AM
#72629   Could be. I think the 'today' number 2damoon1 04/28/16 08:44:11 AM
#72628   (WO2016065028) CRYSTALLINE FORMS OF 5-CHLORO-N4-[-2-(DIMETHYLPHOSPHORYL) PHENYL] LUMA14 04/28/16 08:42:01 AM
#72627   Yah think! greggors 04/28/16 08:10:42 AM
#72626   Sanofi offers 9.3 billion for Medivation which has AK-PROARIAD 04/28/16 06:45:00 AM
#72625   The company is not finished by any measure. biotech_researcher 04/28/16 05:21:36 AM
#72624   Hi - what does this mean hosed? yankees7 04/27/16 10:12:57 PM
#72623   Jess, I only sold some shares that I dogpal2 04/27/16 06:41:02 PM
#72622   Jess, It's difficult for me to do this because ariafan 04/27/16 04:20:46 PM
#72621   Fan/Dog, I'm a little sad to see that Jesspro 04/27/16 04:01:09 PM
#72620   Jess, obviously we need to see the transfer flexinvester 04/27/16 02:41:57 PM
#72619   I sold mine today. I feel like you binks 04/27/16 02:08:22 PM
#72618   They are clearly seeing the writing on the Jesspro 04/27/16 01:27:28 PM
#72617   Short Interest as of 4/15 is $30,312,719 down flexinvester 04/27/16 01:07:14 PM
#72616   If Ariad can't book the French revenue in biotech_researcher 04/27/16 11:09:07 AM
#72615   I have been thinking about this for a ariafan 04/27/16 10:55:59 AM
#72613   Just make sure you are doing what YOU dogpal2 04/27/16 10:52:01 AM
#72612   Same old thing with this stock. I ariafan 04/27/16 09:51:22 AM
#72611   Looks as though we cannot get securely out dogpal2 04/27/16 09:45:56 AM
#72610   Luma, good article...thanks for sharing. Jesspro 04/27/16 07:06:09 AM
PostSubject